SK bioscience Co.,Ltd. (KRX:302440)
South Korea · Delayed Price · Currency is KRW 47,200
-250 (-0.53%)
At close: Jul 25, 2025, 3:30 PM KST
SK bioscience Market Cap
SK bioscience has a market cap or net worth of 3.70 trillion as of July 25, 2025. Its market cap has decreased by -9.67% in one year.
Market Cap
3.70T
Enterprise Value
3.15T
Revenue
399.83B
Ranking
n/a
PE Ratio
n/a
Stock Price
47,200.00
Market Cap Chart
Since March 18, 2021, SK bioscience's market cap has decreased from 12.93T to 3.70T, a decrease of -71.39%. That is a compound annual growth rate of -24.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2025 | 3,699.02B | -6.32% |
| Dec 30, 2024 | 3,948.70B | -28.57% |
| Dec 28, 2023 | 5,528.45B | -2.04% |
| Dec 29, 2022 | 5,643.63B | -67.21% |
| Dec 30, 2021 | 17.21T | 33.14% |
| Mar 18, 2021 | 12.93T | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 77.44T |
| Celltrion | 39.84T |
| ALTEOGEN | 25.49T |
| Yuhan | 9,219.06B |
| SK Biopharmaceuticals | 7,987.95B |
| Peptron | 6,628.10B |
| HLB Co., Ltd. | 6,499.61B |
| PharmaResearch | 6,015.61B |